Jazz Pharmaceuticals plc — Director's Dealing 2014

Mar 6, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Jazz Pharmaceuticals plc (JAZZ)
CIK: 0001232524
Period of Report: 2014-03-04

Reporting Person: Keegan Fintan (EVP, Technical Operations)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-03-04	Ordinary Shares	S	3006	$161.00	Disposed	40906	Direct
2014-03-06	Ordinary Shares	S	1634	$157.89	Disposed	39272	Direct

Footnotes

F1: Shares sold to satisfy tax obligations arising out of vesting of a portion of previously granted restricted stock units.